Dual-controlled drug delivery across biodegradable copolymer. II. Delivery kinetics of levonorgestrel and estradiol from (matrix/matrix) laminate drug delivery system

Journal of Controlled Release

Volumn 41, Issue 3, 1996, Pages 259-269

  Ye, Wei Ping ^a,b   Chien, Yie W ^a  

^a RUTGERS UNIVERSITY   (United States)

^b NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

Author keywords

(Matrix matrix) laminate drug delivery system; Caprolactone and lactide block copolymer; Dual controlled delivery; Estradiol; Implant; Levonorgestrel

Indexed keywords

COPOLYMER; ESTRADIOL; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG MANUFACTURE; DRUG MIXTURE; DRUG RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL;

EID: 0030249645     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(96)01330-2     Document Type: Article

References (14)

1. [1] J. Posti. Design and clinical properties of the contraceptive subdermal implant Norplant®. Sci. Tech. Pract. Pharm. 3 (1987) 309-312.
2. [2] D.N. Robertson, in: D.R. Mishell Jr. (Ed.), Long-acting Steroid Contraception. Raven Press. New York, 1983, pp. 127-147.
3. [3] M.J.D. Eenink, G.C.T. Maassen, A.P. Sam, J.A.A. Geelen, J.B.J.M. Van Lieshout, J. Olijslager, H. de Nijs and E. de Jager, Development of a new long-acting contraceptive subdermal implant releasing 3-ketodesogestrel. Proceedings of the 15th International Symposium on Controlled Release of Bioactive Materials, Controlled Release Society, Lincolnshire. IL. 1988. pp. 402-403.
4. [4] S.J. Ory, C.B. Hammond, S.G. Yancy, R.W. Hendren and C.G. Pitt. The effect of a biodegradable contraceptive capsule (Capronor®) containing levonorgestrel on gonadotropin, estrogen and progesterone levels. Am. J. Obstet. Gynecol. 145 (1983) 600-605.
5. [5] G.I. Dhall, U. Krishna, R. Svaraman, S. Datey, L.N. Gaur, S. Mehta. M. Roy, N.C. Saxena, S.C. Yadav, P. Visnawath and B.B. Saxena, Phase II clinical trial with biodegradable subdermal contraceptive implant Capronor® (4.0-cm single implant). Contraception 44 (1991) 409-417.
6. [6] G. Gupta, B.B. Saxena, R. Landesman and W.J. Ledger, Subcutaneous bioabsorbable pellets of norethindrone for contraception in women: phase I clinical study. Fertil. Steril. 41 (1984) 723-731.
7. [7] M. Singh, B.B. Saxena, R. Landesman and W.J. Ledger, Contraceptive efficacy of bioabsorbable pellets of norethindrone (NET) as subcutaneous implants: phase II clinical study. Adv. Contracept. 1 (1985) 131-149.
8. [8] C.X. Song and X.D. Feng. Preparation of block copolymer of ε-caprolactone and DL-lactide and its degradation. J. Polym. Sci. 593 (1983).
9. [9] Z.W. Gu, W.P. Ye, J.Y. Yang, YX. Li, X.L. Chen, G.W. Zhong and X.D. Feng, Biodegradable block copolymer matrices for long-acting contraceptives with constant release. J. Control. Release 22 (1992) 3-14.
10. [10] Y.X. Li and X.D. Feng, Biodegradable polymeric matrix for long-acting and zero-order release drug delivery systems. Makromol. Chem. Macromol. Symp. 33 (1990) 253-264.
11. [11] W.P. Ye and Y.W. Chien, Dual-controlled drug delivery across biodegradable copolymer. I. Delivery kinetics of levonorgestrel and estradiol through (caprolactone/lactide) block copolymer. J. Pharm. Dev. Technol. 1 (1996) 1-9.
12. [12] Y.W. Chien and K.H. Valia, Development of a dynamic skin permeation system for long-term permeation studies. Drug Dev. Ind. Pharm. 10 (1984) 575-599.
13. [13] M.J.D. Eenink and J. Feijen, Biodegradable hollow fibres for the controlled release of hormones. J. Control. Release 6 (1987) 225-247.
14. [14] Y.W. Chien, Novel Drug Delivery Systems, Second Edn. Marcel Dekker, New York (1992).